US Stock MarketDetailed Quotes
BLACU Bellevue Life Sciences Acquisition Corp.
- 10.940
- 0.0000.00%
Close Jul 19 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low1Volume10.940Open10.940Pre Close11.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares11.47052wk High0.00P/B0Float Cap10.08552wk Low--Dividend TTM0Shs Float11.470Historical High--Div YieldTTM0.00%Amplitude10.085Historical Low11.000Avg Price1Lot Size
About Bellevue Life Sciences Acquisition Corp. Company
Bellevue Life Sciences Acquisition Corp. is a blank check company. Its objectives are to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2020 and is headquartered in Bellevue, WA.
Company Profile
SymbolBLACU
Company NameBellevue Life Sciences Acquisition Corp.
Listing DateFeb 10, 2023
Issue Price10.00
Founded2020
CEOMr. Kuk Hyoun Hwang
MarketNASDAQ
Employees2
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address10900 NE 4th Street,Suite 2300
CityBellevue
ProvinceWashington
CountryUnited States of America
Zip Code98004
Phone1-425-635-7700
Websitehttps://www.bellevuespac.com
Company Executives
- Name
- Position
- Salary
- Kuk Hyoun Hwang
- Chief Executive Officer and Director
- --
- David Jin Yoo
- Chief Financial Officer and Principal Accounting Officer
- --
- Jun Chul Whang
- Director
- --
- Jin Whan Park
- Independent Director
- --
- Sang Hyun Kim
- Independent Director
- --
- Phil Geon Lee
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg